Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea

VaxigripTetra® (Sanofi Pasteur, Lyon, France) is a quadrivalent split-virion inactivated influenza vaccine (IIV4) containing two B-lineage strains approved in the European Union and Taiwan in 2016 for individuals ≥ 3 years of age. Here, we describe an observer-blind, randomized, controlled, multicen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hum Vaccin Immunother
Glavni autori: Choi, Won Suk, Noh, Ji Yun, Lee, Jacob, Choi, Jun Yong, Lee, Jin-Soo, Kim, Moo Soo, Kim, Hee Soo, Bang, Joon, Lavis, Nathalie, Kim, Woo Joo
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861787/
https://ncbi.nlm.nih.gov/pubmed/28933625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1381808
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items